• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成羟基磷灰石在体外抑制双膦酸盐对口腔黏膜的毒性。

Synthetic Hydroxyapatite Inhibits Bisphosphonate Toxicity to the Oral Mucosa In Vitro.

作者信息

Bullock George, Miller Cheryl, McKechnie Alasdair, Hearnden Vanessa

机构信息

Department of Materials Science and Engineering, The University of Sheffield, Sheffield S3 7HQ, UK.

School of Clinical Dentistry, The University of Sheffield, Sheffield S10 2TA, UK.

出版信息

Materials (Basel). 2020 May 1;13(9):2086. doi: 10.3390/ma13092086.

DOI:10.3390/ma13092086
PMID:32369961
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7254283/
Abstract

Medication-related osteonecrosis of the jaw (MRONJ) is a side effect of bisphosphonate therapy, characterised by exposed necrotic bone. The soft tissues of the oral mucosa no longer provide a protective barrier and MRONJ patients experience pain, infections and difficulties eating. We hypothesised that hydroxyapatite (Ca(PO)(OH)) could reduce bisphosphonate concentrations and protect the oral mucosa by exploiting bisphosphonate's calcium binding affinity. The effect of zoledronic acid (ZA) and pamidronic acid (PA) on the metabolism of oral fibroblasts, oral keratinocytes and three-dimensional oral mucosa models was investigated and then repeated in the presence of hydroxyapatite granules. Without hydroxyapatite, ZA and PA significantly reduced the metabolic activity of oral cells in a dose-dependent manner. Both drugs reduced epithelial thickness and 30 µM ZA resulted in loss of the epithelium. Hydroxyapatite granules had a protective effect on oral cells, with metabolic activity retained. Oral mucosa models retained their multi-layered epithelium when treated with ZA in the presence of hydroxyapatite granules and metabolic activity was comparable to controls. These results demonstrate hydroxyapatite granules protected oral soft tissues from damage caused by bisphosphonate exposure. Porous hydroxyapatite granules are currently used for socket preservation and this data suggests their potential to prevent MRONJ in at-risk patients.

摘要

药物相关性颌骨坏死(MRONJ)是双膦酸盐治疗的一种副作用,其特征为暴露的坏死骨。口腔黏膜的软组织不再提供保护屏障,MRONJ患者会经历疼痛、感染和进食困难。我们假设羟基磷灰石(Ca(PO)(OH))可以通过利用双膦酸盐的钙结合亲和力来降低双膦酸盐浓度并保护口腔黏膜。研究了唑来膦酸(ZA)和帕米膦酸(PA)对口腔成纤维细胞、口腔角质形成细胞和三维口腔黏膜模型代谢的影响,然后在存在羟基磷灰石颗粒的情况下重复进行。在没有羟基磷灰石的情况下,ZA和PA以剂量依赖的方式显著降低口腔细胞的代谢活性。两种药物均降低上皮厚度,30 µM ZA导致上皮丧失。羟基磷灰石颗粒对口腔细胞具有保护作用,代谢活性得以保留。在存在羟基磷灰石颗粒的情况下用ZA处理时,口腔黏膜模型保留了其多层上皮,且代谢活性与对照组相当。这些结果表明羟基磷灰石颗粒可保护口腔软组织免受双膦酸盐暴露所致的损伤。多孔羟基磷灰石颗粒目前用于牙槽窝保存,该数据表明其在预防高危患者发生MRONJ方面的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b396/7254283/21aaf386c526/materials-13-02086-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b396/7254283/818522b9bddf/materials-13-02086-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b396/7254283/ae26d9a0b7a1/materials-13-02086-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b396/7254283/9955c74a1a06/materials-13-02086-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b396/7254283/dd30f3a2aa64/materials-13-02086-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b396/7254283/21aaf386c526/materials-13-02086-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b396/7254283/818522b9bddf/materials-13-02086-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b396/7254283/ae26d9a0b7a1/materials-13-02086-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b396/7254283/9955c74a1a06/materials-13-02086-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b396/7254283/dd30f3a2aa64/materials-13-02086-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b396/7254283/21aaf386c526/materials-13-02086-g005.jpg

相似文献

1
Synthetic Hydroxyapatite Inhibits Bisphosphonate Toxicity to the Oral Mucosa In Vitro.合成羟基磷灰石在体外抑制双膦酸盐对口腔黏膜的毒性。
Materials (Basel). 2020 May 1;13(9):2086. doi: 10.3390/ma13092086.
2
Effect of Geranylgeraniol (GGOH) on Bisphosphonate-Induced Cytotoxicity of Oral Mucosa Cells.香叶基香叶醇(GGOH)对双膦酸盐诱导的口腔黏膜细胞毒性的影响。
Front Oral Health. 2022 Jun 20;3:892615. doi: 10.3389/froh.2022.892615. eCollection 2022.
3
A Review Into the Effects of Pamidronic Acid and Zoledronic Acid on the Oral Mucosa in Medication-Related Osteonecrosis of the Jaw.帕米膦酸和唑来膦酸对颌骨药物相关性骨坏死口腔黏膜影响的综述
Front Oral Health. 2022 Feb 9;2:822411. doi: 10.3389/froh.2021.822411. eCollection 2021.
4
Combinatorial effects of hydroxyapatite and Tualang honey on medication-related osteonecrosis of the jaw (MRONJ): An in vitro study.羟基磷灰石与土琅蜂蜜对药物性颌骨坏死(MRONJ)的联合作用:一项体外研究。
J Stomatol Oral Maxillofac Surg. 2025 Feb;126(1):101999. doi: 10.1016/j.jormas.2024.101999. Epub 2024 Jul 30.
5
Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.唑来膦酸治疗小鼠牙槽骨骨坏死中,挽救性双膦酸盐治疗可改善拔牙窝愈合。
Bone. 2019 Jun;123:115-128. doi: 10.1016/j.bone.2019.03.027. Epub 2019 Mar 26.
6
Inflammation Can Be a High-Risk Factor for Mucosal Nonunion of MRONJ by Regulating SIRT1 Signaling When Treated with an Oncologic Dose of Zoledronate.当使用唑来膦酸的肿瘤剂量治疗时,炎症可以通过调节 SIRT1 信号成为 MRONJ 黏膜不愈合的高危因素。
Drug Des Devel Ther. 2024 Jul 4;18:2793-2812. doi: 10.2147/DDDT.S456811. eCollection 2024.
7
Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice.在小鼠中,以化疗剂量依赖性方式增加了双膦酸盐相关性颌骨样病变的发生率。
Bone. 2018 Jul;112:177-186. doi: 10.1016/j.bone.2018.05.001. Epub 2018 May 2.
8
Medication-related osteonecrosis of the jaw-like lesions in rodents: A comprehensive systematic review and meta-analysis.啮齿动物药物相关性颌骨样骨坏死病变:全面的系统评价和荟萃分析。
Gerodontology. 2019 Dec;36(4):313-324. doi: 10.1111/ger.12416. Epub 2019 Aug 2.
9
CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.抗吸收剂相关性颌骨坏死/药物相关性颌骨坏死的 CT 影像学特征。
Dentomaxillofac Radiol. 2018 May;47(4):20170323. doi: 10.1259/dmfr.20170323. Epub 2018 Feb 13.
10
Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: A systematic review and meta-analysis.接受地舒单抗和唑来膦酸治疗的癌症患者的药物相关性颌骨坏死(MRONJ):系统评价和荟萃分析。
Med Oral Patol Oral Cir Bucal. 2020 May 1;25(3):e326-e336. doi: 10.4317/medoral.23324.

引用本文的文献

1
Inflammation Can Be a High-Risk Factor for Mucosal Nonunion of MRONJ by Regulating SIRT1 Signaling When Treated with an Oncologic Dose of Zoledronate.当使用唑来膦酸的肿瘤剂量治疗时,炎症可以通过调节 SIRT1 信号成为 MRONJ 黏膜不愈合的高危因素。
Drug Des Devel Ther. 2024 Jul 4;18:2793-2812. doi: 10.2147/DDDT.S456811. eCollection 2024.
2
Impact of beta-tricalcium phosphate on preventing tooth extraction-triggered bisphosphonate-related osteonecrosis of the jaw in rats.β-磷酸三钙对预防大鼠拔牙后引发的双膦酸盐相关性颌骨坏死的影响。
Sci Rep. 2023 Sep 25;13(1):16032. doi: 10.1038/s41598-023-43315-3.
3
In Vitro Cytotoxicity of Antiresorptive and Antiangiogenic Compounds on Oral Tissues Contributing to MRONJ: Systematic Review.

本文引用的文献

1
Synthetic Calcium Phosphate Ceramics as a Potential Treatment for Bisphosphonate-Related Osteonecrosis of the Jaw.合成磷酸钙陶瓷作为颌骨双膦酸盐相关骨坏死的一种潜在治疗方法。
Materials (Basel). 2019 Jun 6;12(11):1840. doi: 10.3390/ma12111840.
2
"Spontaneous" medication-related osteonecrosis of the jaw; two case reports and a systematic review."自发性"药物相关性下颌骨坏死;两例报告和系统评价。
Aust Dent J. 2018 Dec;63(4):441-454. doi: 10.1111/adj.12648. Epub 2018 Sep 9.
3
Cytotoxic and inflammatory effects of alendronate and zolendronate on human osteoblasts, gingival fibroblasts and osteosarcoma cells.
抗吸收和抗血管生成化合物对口腔组织的体外细胞毒性与 MRONJ 有关:系统评价。
Biomolecules. 2023 Jun 10;13(6):973. doi: 10.3390/biom13060973.
4
Zoledronic acid affects the process of infecting oral mucosal epithelial barrier: An and study.唑来膦酸影响感染口腔黏膜上皮屏障的过程:一项体内和体外研究。
Front Cell Infect Microbiol. 2023 Mar 28;13:1104826. doi: 10.3389/fcimb.2023.1104826. eCollection 2023.
5
Effect of Geranylgeraniol (GGOH) on Bisphosphonate-Induced Cytotoxicity of Oral Mucosa Cells.香叶基香叶醇(GGOH)对双膦酸盐诱导的口腔黏膜细胞毒性的影响。
Front Oral Health. 2022 Jun 20;3:892615. doi: 10.3389/froh.2022.892615. eCollection 2022.
6
A Review Into the Effects of Pamidronic Acid and Zoledronic Acid on the Oral Mucosa in Medication-Related Osteonecrosis of the Jaw.帕米膦酸和唑来膦酸对颌骨药物相关性骨坏死口腔黏膜影响的综述
Front Oral Health. 2022 Feb 9;2:822411. doi: 10.3389/froh.2021.822411. eCollection 2021.
7
An Overview of Physical, Microbiological and Immune Barriers of Oral Mucosa.口腔黏膜的物理、微生物和免疫屏障概述。
Int J Mol Sci. 2021 Jul 22;22(15):7821. doi: 10.3390/ijms22157821.
8
Nutritional, Antioxidant, Antimicrobial, and Toxicological Profile of Two Innovative Types of Vegan, Sugar-Free Chocolate.两种创新型纯素无糖巧克力的营养、抗氧化、抗菌及毒理学特性
Foods. 2020 Dec 11;9(12):1844. doi: 10.3390/foods9121844.
阿伦膦酸盐和唑来膦酸盐对人成骨细胞、牙龈成纤维细胞和骨肉瘤细胞的细胞毒性和炎症作用。
J Craniomaxillofac Surg. 2018 Apr;46(4):538-546. doi: 10.1016/j.jcms.2017.12.015. Epub 2018 Jan 10.
4
Removal of matrix-bound zoledronate prevents post-extraction osteonecrosis of the jaw by rescuing osteoclast function.去除基质结合唑来膦酸可通过挽救破骨细胞功能来预防拔牙后颌骨坏死。
Bone. 2018 May;110:141-149. doi: 10.1016/j.bone.2018.01.030. Epub 2018 Feb 9.
5
Effects of an oral bisphosphonate and three intravenous bisphosphonates on several cell types in vitro.口服双膦酸盐和三种静脉用双膦酸盐对几种细胞类型的体外影响。
Clin Oral Investig. 2018 Sep;22(7):2527-2534. doi: 10.1007/s00784-018-2349-6. Epub 2018 Feb 1.
6
Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease.颌骨药物相关性骨坏死的患病率是否被低估:肿瘤及非肿瘤疾病中的评估
Bratisl Lek Listy. 2017;118(12):724-731. doi: 10.4149/BLL_2017_137.
7
Use of a Rho kinase inhibitor to increase human tonsil keratinocyte longevity for three-dimensional, tissue engineered tonsil epithelium equivalents.使用 Rho 激酶抑制剂增加人扁桃体角质形成细胞的寿命,用于三维组织工程化的扁桃体上皮等效物。
J Tissue Eng Regen Med. 2018 Mar;12(3):e1636-e1646. doi: 10.1002/term.2590. Epub 2017 Dec 3.
8
A Strategy against the Osteonecrosis of the Jaw Associated with Nitrogen-Containing Bisphosphonates (N-BPs): Attempts to Replace N-BPs with the Non-N-BP Etidronate.一种针对含氮双膦酸盐(N-BPs)相关颌骨坏死的策略:尝试用非N-BP依替膦酸替代N-BPs。
Biol Pharm Bull. 2016;39(9):1549-54. doi: 10.1248/bpb.b16-00041.
9
Adipose-derived stem cells and platelet-rich plasma for preventive treatment of bisphosphonate-related osteonecrosis of the jaw in a murine model.脂肪来源干细胞和富血小板血浆对小鼠模型中双膦酸盐相关颌骨坏死的预防性治疗
J Craniomaxillofac Surg. 2015 Sep;43(7):1161-8. doi: 10.1016/j.jcms.2015.04.026. Epub 2015 May 9.
10
Bisphosphonate-related osteonecrosis of the jaw: specificities.双膦酸盐相关颌骨坏死:特点
Oncol Rev. 2014 Sep 23;8(2):254. doi: 10.4081/oncol.2014.254.